Receptor activity-modifying protein 1 regulates the differentiation of mouse skin fibroblasts by downregulating α-SMA expression via suppression of high mobility group AT-hook 1 to promote skin wound repair

Abstract

Background: Skin innervation is very important for normal wound healing, and receptor activity-modifying protein 1 (RAMP1) has been reported to modulate calcitonin gene-related peptide (CGRP) receptor function and thus be a potential treatment target. This study aimed to elucidate the intricate regulatory effect of RAMP1 on skin fibroblast function, thereby addressing the existing knowledge gap in this area. Methods: Immunohistochemical staining and immunofluorescence (IF) staining were used to measure the dynamic changes in the expression of RAMP1 and α-smooth muscle actin (α-SMA) in skin wound tissue in mice. Mouse skin fibroblasts (MSFs) stably transfected with Tet-on-Flag-RAMP1 overexpression (OE) and Tet-on-Flag control (Ctrl) lentiviruses were constructed for in vitro experiments. High mobility group AT-hook 1 (HMGA1) plasmids and α-SMA plasmids were used to overexpress HMGA1 and α-SMA, respectively. An α-SMA siRNA was used to silence α-SMA. Quantitative real-time polymerase chain reaction (qPCR), western blot and IF staining analyses were used to determine the mRNA and protein levels in the cells in different groups. A scratch wound healing assay was used to evaluate the cell migration ability of different groups. Cleavage under targets and release using nuclease (CUT & RUN) assays and dual-luciferase reporter assays were used to predict and verify the interaction between HMGA1 and the α-SMA promoter. Results: RAMP1 and α-SMA protein expression levels in the dermis changed dynamically and were negatively correlated during dorsal skin wound healing in mice. RAMP1 OE in vitro inhibited the differentiation and promoted the migration of MSFs by decreasing α-SMA expression via the suppression of HMGA1, which was shown for the first time to bind to the α-SMA promoter and increase α-SMA transcription. RAMP1 OE also modulated extracellular matrix (ECM) synthesis and remodeling by promoting collagen III and MMP9 expression and decreasing collagen I, MMP2, and tissue inhibitor of metalloproteinases 1 expression. Conclusions: Our findings suggest that RAMP1 OE decreases differentiation and promotes migration in MSFs by downregulating α-SMA expression via the suppression of HMGA1 and modulates ECM synthesis and remodeling, revealing a novel mechanism regulating α-SMA transcription, providing new insights into the RAMP1-mediated regulation of fibroblast function, and identifying effective nerve-related targets for skin wound repair.

Keywords

Fibroblast differentiation / High mobility group AT-hook 1 / Myofibroblast / Receptor activity-modifying protein 1 / Skin wound healing / α-smooth muscle actin

References

[1] Lynch MD, Watt FM. Fibroblast heterogeneity: implications for human disease. J Clin Invest. 2018; 128: 26-35. https://doi.org/10.1172/JCI93555.

[2] Darby IA, Zakuan N, Billet F, Desmoulière A. The myofibroblast, a key cell in normal and pathological tissue repair. Cell Mol Life Sci. 2016; 73: 1145-57. https://doi.org/10.1007/s00018-015-2110-0.

[3] Gurtner GC, Werner S, Barrandon Y, Longaker MT. Wound repair and regeneration. Nature. 2008; 453: 314-21. https://doi.org/10.1038/nature07039.

[4] Grinnell F.Fibroblasts, myofibroblasts, and wound contraction. J Cell Biol. 1994; 124: 401-4. https://doi.org/10.1083/jcb.124.4.401.

[5] Shu DY, Lovicu FJ. Myofibroblast transdifferentiation: the dark force in ocular wound healing and fibrosis. Prog Retin Eye Res. 2017; 60: 44-65. https://doi.org/10.1016/j.preteyeres.2017.08.001.

[6] Zhou M, Zhao X, Liao L, Deng Y, Liu M, Wang J, et al. Forsythiaside a regulates activation of hepatic stellate cells by inhibiting NOX4-dependent ROS. Oxidative Med Cell Longev. 2022; 2022: 1-17. https://doi.org/10.1155/2022/9938392.

[7] Mascharak S, Desjardins-Park HE, Davitt MF, Griffin M, Borrelli MR, Moore AL, et al. Preventing Engrailed-1 activation in fibroblasts yields wound regeneration without scarring. Science. 2021; 372: eaba2374. https://doi.org/10.1126/science.aba2374.

[8] Leavitt T, Hu MS, Borrelli MR, Januszyk M, Garcia JT, Ransom RC, et al. Prrx1 fibroblasts represent a pro-fibrotic lineage in the mouse ventral dermis. Cell Rep. 2020; 33: 108356. https://doi.org/10.1016/j.celrep.2020.108356.

[9] Shook BA, Wasko RR, Rivera-Gonzalez GC, Salazar-Gatzimas E, López-Giráldez F, Dash BC, et al. Myofibroblast proliferation and heterogeneity are supported by macrophages during skin repair. Science. 2018; 362: eaar2971. https://doi.org/10.1126/science.aar2971.

[10] Davis FM, Tsoi LC, Wasikowski R, denDekker A, Joshi A, Wilke C, et al. Epigenetic regulation of the PGE2 pathway modulates macrophage phenotype in normal and pathologic wound repair. JCI Insight. 2020; 5:e138443. https://doi.org/10.1172/jci.insight.138443.

[11] Limandjaja GC, Belien JM, Scheper RJ, Niessen FB, Gibbs S. Hypertrophic and keloid scars fail to progress from the CD34(−)/α-smooth muscle actin (α-SMA)(+) immature scar phenotype and show gradient differences in α-SMA and p16 expression. Br J Dermatol. 2020; 182: 974-86. https://doi.org/10.1111/bjd.18219.

[12] Lebonvallet N, Laverdet B, Misery L, Desmoulière A, Girard D. New insights into the roles of myofibroblasts and innervation during skin healing and innovative therapies to improve scar innervation. Exp Dermatol. 2018; 27: 950-8. https://doi.org/10.1111/exd.13681.

[13] McAndrews KM, Miyake T, Ehsanipour EA, Kelly PJ, Becker LM, McGrail DJ, et al. Dermal αSMA(+) myofibroblasts orchestrate skin wound repair via β1 integrin and independent of type I collagen production. EMBO J. 2022; 41:e109470. https://doi.org/10.15252/embj.2021109470.

[14] Liu Z, Cao Y, Liu G, Yin S, Ma J, Liu J, et al. p75 neurotrophin receptor regulates NGF-induced myofibroblast differentiation and collagen synthesis through MRTF-A. Exp Cell Res. 2019; 383: 111504. https://doi.org/10.1016/j.yexcr.2019.111504.

[15] Ellis A, Bennett DL. Neuroinflammation and the generation of neuropathic pain. Br J Anaesth. 2013; 111: 26-37. https://doi.org/10.1093/bja/aet128.

[16] Granstein RD, Wagner JA, Stohl LL, Ding W. Calcitonin gene-related peptide: key regulator of cutaneous immunity. Acta Physiol (Oxf). 2015; 213: 586-94. https://doi.org/10.1111/apha.12442.

[17] Toda M, Suzuki T, Hosono K, Kurihara Y, Kurihara H, Hayashi I, et al. Roles of calcitonin gene-related peptide in facilitation of wound healing and angiogenesis. Biomed Pharmacother. 2008; 62: 352-9. https://doi.org/10.1016/j.biopha.2008.02.003.

[18] Roggenkamp D, Köpnick S, Stäb F, Wenck H, Schmelz M, Neufang G. Epidermal nerve fibers modulate keratinocyte growth via neuropeptide signaling in an innervated skin model. J Invest Dermatol. 2013; 133: 1620-8. https://doi.org/10.1038/jid.2012.464.

[19] Wurthmann S, Nägel S, Hadaschik E, Schlott S, Scheffler A, Kleinschnitz C, et al. Impaired wound healing in a migraine patient as a possible side effect of calcitonin gene-related peptide receptor antibody treatment: a case report. Cephalalgia. 2020; 40: 1255-60. https://doi.org/10.1177/0333102420933571.

[20] Chéret J, Lebonvallet N, Buhé V, Carre JL, Misery L, Le Gall-Ianotto C. Influence of sensory neuropeptides on human cutaneous wound healing process. J Dermatol Sci. 2014; 74: 193-203. https://doi.org/10.1016/j.jdermsci.2014.02.001.

[21] Holzer P.Neurogenic vasodilatation and plasma leakage in the skin. Gen Pharmacol. 1998; 30: 5-11. https://doi.org/10.1016/S0306-3623(97)00078-5.

[22] Russell FA, King R, Smillie SJ, Kodji X, Brain SD. Calcitonin gene-related peptide: physiology and pathophysiology. Physiol Rev. 2014; 94: 1099-142. https://doi.org/10.1152/physrev.00034.2013.

[23] Hinson JP, Kapas S, Smith DM. Adrenomedullin, a multifunctional regulatory peptide. Endocr Rev. 2000; 21: 138-67.

[24] Dickerson IM. Role of CGRP-receptor component protein (RCP) in CLR/RAMP function. Curr Protein Pept Sci. 2013; 14: 407-15. https://doi.org/10.2174/13892037113149990057.

[25] Evans BN, Rosenblatt MI, Mnayer LO, Oliver KR, Dickerson IM. CGRP-RCP, a novel protein required for signal transduction at calcitonin gene-related peptide and adrenomedullin receptors. J Biol Chem. 2000; 275: 31438-43. https://doi.org/10.1074/jbc.M005604200.

[26] Prado MA, Evans-Bain B, Oliver KR, Dickerson IM. The role of the CGRP-receptor component protein (RCP) in adrenomedullin receptor signal transduction. Peptides. 2001; 22: 1773-81. https://doi.org/10.1016/S0196-9781(01)00517-4.

[27] McLatchie LM, Fraser NJ, Main MJ, Wise A, Brown J, Thompson N, et al. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature. 1998; 393: 333-9. https://doi.org/10.1038/30666.

[28] Qi T, Hay DL. Structure-function relationships of the N-terminus of receptor activity-modifying proteins. Br J Pharmacol. 2010; 159: 1059-68. https://doi.org/10.1111/j.1476-5381.2009.00541.x.

[29] Laschinger M, Wang Y, Holzmann G, Wang B, Stöß C, Lu M, et al. The CGRP receptor component RAMP1 links sensory innervation with YAP activity in the regenerating liver. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2020; 34: 8125-38. https://doi.org/10.1096/fj.201903200R.

[30] Zhao Z, Fu X, Zhang G, Li Y, Wu M, Tan Y. The influence of RAMP1 overexpression on CGRP-induced osteogenic differentiation in MG-63 cells in vitro: an experimental study. J Cell Biochem. 2013; 114: 314-22. https://doi.org/10.1002/jcb.24375.

[31] Hay DL, Poyner DR, Sexton PM. GPCR modulation by RAMPs. Pharmacol Ther. 2006; 109: 173-97. https://doi.org/10.1016/j.pharmthera.2005.06.015.

[32] Udawela M, Hay DL, Sexton PM. The receptor activity modifying protein family of G protein coupled receptor accessory proteins. Semin Cell Dev Biol. 2004; 15: 299-308. https://doi.org/10.1016/j.semcdb.2003.12.019.

[33] Klein KR, Matson BC, Caron KM. The expanding repertoire of receptor activity modifying protein (RAMP) function. Crit Rev Biochem Mol Biol. 2016; 51: 65-71. https://doi.org/10.3109/10409238.2015.1128875.

[34] Kurashige C, Hosono K, Matsuda H, Tsujikawa K, Okamoto H, Majima M. Roles of receptor activity-modifying protein 1 in angiogenesis and lymphangiogenesis during skin wound healing in mice. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2014; 28: 1237-47. https://doi.org/10.1096/fj.13-238998.

[35] Yin S, Song R, Ma J, Liu C, Wu Z, Cao G, et al. Receptor activity-modifying protein 1 regulates mouse skin fibroblast proliferation via the Gαi3-PKA-CREB-YAP axis. Cell Commun Signal. 2022; 20: 52. https://doi.org/10.1186/s12964-022-00852-0.

[36] Zhang M, Cao Y, Li X, Hu L, Taieb SK, Zhu X, et al. Cd271 mediates proliferation and differentiation of epidermal stem cells to support cutaneous burn wound healing. Cell Tissue Res. 2018; 371: 273-82. https://doi.org/10.1007/s00441-017-2723-8.

[37] Zhang M, Zhang Y, Ding J, Li X, Zang C, Yin S, et al. The role of TrkA in the promoting wounding-healing effect of CD271 on epidermal stem cells. Arch Dermatol Res. 2018; 310: 737-50. https://doi.org/10.1007/s00403-018-1863-3.

[38] Zhang M, Zhang R, Li X, Cao Y, Huang K, Ding J, et al. CD271 promotes STZ-induced diabetic wound healing and regulates epidermal stem cell survival in the presence of the pTrkA receptor. Cell Tissue Res. 2020; 379: 181-93. https://doi.org/10.1007/s00441-019-03125-4.

[39] Hasan W, Zhang R, Liu M, Warn JD, Smith PG. Coordinate expression of NGF and alpha-smooth muscle actin mRNA and protein in cutaneous wound tissue of developing and adult rats. Cell Tissue Res. 2000; 300: 97-109.

[40] Shinde AV, Humeres C, Frangogiannis NG. The role of α-smooth muscle actin in fibroblast-mediated matrix contraction and remodeling. Biochim Biophys Acta Mol basis Dis. 2017; 1863: 298-309. https://doi.org/10.1016/j.bbadis.2016.11.006.

[41] Chin MT, Pellacani A, Wang H, Lin SS, Jain MK, Perrella MA, et al. Enhancement of serum-response factor-dependent transcription and DNA binding by the architectural transcription factor HMG-I(Y). J Biol Chem. 1998; 273: 9755-60. https://doi.org/10.1074/jbc.273.16.9755.

[42] Hay DL, Pioszak AA. Receptor activity-modifying proteins (RAMPs): new insights and roles. Annu Rev Pharmacol Toxicol. 2016; 56: 469-87. https://doi.org/10.1146/annurev-pharmtox-010715-103120.

[43] Routledge SJ, Ladds G, Poyner DR. The effects of RAMPs upon cell signalling. Mol Cell Endocrinol. 2017; 449: 12-20. https://doi.org/10.1016/j.mce.2017.03.033.

[44] Penn JW, Grobbelaar AO, Rolfe KJ.The role of the TGF-β family in wound healing, burns and scarring: a review. Int J Burns Trauma. 2012; 2: 18-28.

[45] Gabbiani G.The myofibroblast in wound healing and fibrocontractive diseases. J Pathol. 2003; 200: 500-3. https://doi.org/10.1002/path.1427.

[46] Kawamoto M, Matsunami T, Ertl RF, Fukuda Y, Ogawa M, Spurzem JR, et al. Selective migration of alpha-smooth muscle actin-positive myofibroblasts toward fibronectin in the Boyden’s blindwell chamber. Clin Sci (Lond). 1997; 93: 355-62. https://doi.org/10.1042/cs0930355.

[47] Li Y, Li C, Liu Q, Wang L, Bao AX, Jung JP, et al. Loss of Acta2 in cardiac fibroblasts does not prevent the myofibroblast differentiation or affect the cardiac repair after myocardial infarction. J Mol Cell Cardiol. 2022; 171: 117-32. https://doi.org/10.1016/j.yjmcc.2022.08.003.

[48] Burr SD, Harmon MB Jr, JAS. The impact of diabetic conditions and AGE/RAGE Signaling on cardiac fibroblast migration. Front Cell Dev Biol. 2020; 8: 112. https://doi.org/10.3389/fcell.2020.00112.

[49] Rønnov-Jessen L, Petersen OW. A function for filamentous alpha-smooth muscle actin: retardation of motility in fibroblasts. J Cell Biol. 1996; 134: 67-80. https://doi.org/10.1083/jcb.134.1.67.

[50] Liu Z, Chang AN, Grinnell F, Trybus KM, Milewicz DM, Stull JT, et al. Vascular disease-causing mutation, smooth muscle α-actin R258C, dominantly suppresses functions of α-actin in human patient fibroblasts. Proc Natl Acad Sci USA. 2017; 114: E5569-78. https://doi.org/10.1073/pnas.1703506114.

[51] Madlener M. Differential expression of matrix metalloproteinases and their physiological inhibitors in acute murine skin wounds. Arch Dermatol Res. 1998; 290: S24-9. https://doi.org/10.1007/PL00007450.

[52] Soo C, Shaw WW, Zhang X, Longaker MT, Howard EW, Ting K. Differential expression of matrix metalloproteinases and their tissue-derived inhibitors in cutaneous wound repair. Plast Reconstr Surg. 2000; 105: 638-47. https://doi.org/10.1097/00006534-200002000-00024.

[53] Moretti L, Stalfort J, Barker TH, Abebayehu D. The interplay of fibroblasts, the extracellular matrix, and inflammation in scar formation. J Biol Chem. 2022; 298: 101530. https://doi.org/10.1016/j.jbc.2021.101530.

[54] Johnson KR, Lehn DA, Reeves R. Alternative processing of mRNAs encoding mammalian chromosomal high-mobility-group proteins HMG-I and HMG-Y. Mol Cell Biol. 1989; 9: 2114-23.

[55] Parisi S, Piscitelli S, Passaro F, Russo T. HMGA proteins in Stemness and differentiation of embryonic and adult stem cells. Int J Mol Sci. 2020; 21: 362. https://doi.org/10.3390/ijms21010362.

[56] Shah SN, Kerr C, Cope L, Zambidis E, Liu C, Hillion J, et al. HMGA1 reprograms somatic cells into pluripotent stem cells by inducing stem cell transcriptional networks. PLoS One. 2012; 7: e48533. https://doi.org/10.1371/journal.pone.0048533.

[57] Zhao C, Li Y, Zhang W, Zhao D, Ma L, Ma P, et al. IL-17 induces NSCLC A549 cell proliferation via the upregulation of HMGA1, resulting in an increased cyclin D1 expression. Int J Oncol. 2018; 52: 1579-92. https://doi.org/10.3892/ijo.2018.4307.

[58] Zhang S, Lei R, Wu J, Shan J, Hu Z, Chen L, et al. Role of high mobility group A1 and body mass index in the prognosis of patients with breast cancer. Oncol Lett. 2017; 14: 5719-26. https://doi.org/10.3892/ol.2017.6963.

[59] Fu F, Wang T, Wu Z, Feng Y, Wang W, Zhou S, et al. HMGA1 exacerbates tumor growth through regulating the cell cycle and accelerates migration/invasion via targeting miR-221/222 in cervical cancer. Cell Death Dis. 2018; 9: 594. https://doi.org/10.1038/s41419-018-0683-x.

[60] Egawa N, Hamanaka G, Chung KK, Ishikawa H, Shindo A, Maki T, et al. High mobility group A1 regulates transcription levels of oligodendrocyte marker genes in cultured oligodendrocyte precursor cells. Int J Mol Sci. 2022; 23: 2236. https://doi.org/10.3390/ijms23042236.

[61] Xie Q, Yao Q, Hu T, Cai Z, Zhao J, Yuan Y, et al. High-mobility group A1 promotes cardiac fibrosis by upregulating FOXO1 in fibroblasts. Front Cell Dev Biol. 2021; 9: 666422. https://doi.org/10.3389/fcell.2021.666422.

[62] Strauch AR, Hariharan S. Dynamic interplay of smooth muscle α-actin gene-regulatory proteins reflects the biological complexity of Myofibroblast differentiation. Biology (Basel). 2013; 2: 555-86. https://doi.org/10.3390/biology2020555.

[63] Hopper RK, Moonen JR, Diebold I, Cao A, Rhodes CJ, Tojais NF, et al. In pulmonary arterial hypertension, reduced BMPR2 promotes endothelial-to-mesenchymal transition via HMGA1 and its target slug. Circulation. 2016; 133: 1783-94. https://doi.org/10.1161/CIRCULATIONAHA.115.020617.

[64] Tang PM, Zhang YY, Xiao J, Tang PC, Chung JY, Li J, et al. Neural transcription factor Pou4f1 promotes renal fibrosis via macrophage-myofibroblast transition. Proc Natl Acad Sci USA. 2020; 117: 20741-52. https://doi.org/10.1073/pnas.1917663117.